Table 3 Relative risk of new onset diabetic complications by patient characteristics

Age

1.006 (1.005–1.007)^a

Men (Ref. women)

0.93 (0.92–0.95)^a

CCI

1.018 (1.013–1.023)^a

Baseline DCSI

1.26 (1.25–1.27)^a

Insulin

1.07 (1.03–1.11)^a

Aspirin

1.07 (1.06–1.09)^a

Clopidogrel

0.96 (0.94–0.98)^a

Sarpogrelate

1.00 (0.97–1.02)

Cilostazol

0.99 (0.95–1.03)

ACEI/ARB

0.99 (0.98–1.01)

Statin

0.92 (0.91–0.93)^a

 1

Reference

 2

1.01 (1.00–1.03)

 3 +

1.13 (1.10–1.17)^a

  Metformin

Reference

  DPP4-I

0.77 (0.70–0.85)^a

  Sulfonylurea

1.29 (1.27–1.32)^a

  Glucosidase

1.25 (1.18–1.33)^a

  Metformin + Sulfonylurea

Reference

  Metformin + DPP4-I

0.71 (0.69–0.73)^a